Early downregulation of P-glycoprotein facilitates bacterial attachment to intestinal epithelial cells and thereby triggers barrier dysfunction in a rodent model of total parenteral nutrition

• Published in: The FASEB journal Vol. 34; no. 3; p. 4670
• Main Authors: Zhang, Tian, Liu, Yang, Yan, Jun-Kai, Cai, Wei
• Format: Journal Article
• Language: English
• Published: United States 01.03.2020
• Subjects: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics; ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism; Blotting, Western; Caco-2 Cells; Epithelial Cells - metabolism; Epithelial Cells - microbiology; Escherichia coli - physiology; Humans; Intestines - cytology; Male; Matrix Metalloproteinases - genetics; Matrix Metalloproteinases - metabolism; Occludin - genetics; Occludin - metabolism; Parenteral Nutrition, Total - methods; Protein Stability; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; P-glycoprotein; intestinal barrier function; total parenteral nutrition; Escherichia coli; Occludin
• ISSN: 1530-6860
• DOI: 10.1096/fj.201902513R

Intestinal barrier dysfunction is a major complication of total parenteral nutrition (TPN). Our preliminary study revealed that intestinal P-glycoprotein (P-gp) was significantly downregulated under TPN treatment followed by disruption of barrier function, and thus the significance of early downregulation of P-gp needs to be addressed. Herein, we report a pivotal role of P-gp in the development of intestinal barrier dysfunction under TPN. Functional suppression of P-gp may facilitate bacterial attachment to intestinal epithelial cells (IECs) and thereby induce degradation of tight junctions to trigger barrier dysfunction. By using a rat model of TPN, we found early downregulation of P-gp function in ileum after 3-day TPN, followed by disruption of barrier function after 7-day TPN. By using Escherichia coli (E. coli) k88 and DH5α as type strains, we found significantly increased bacterial attachment to IECs in TPN group compared to sham. By using Caco-2 cells as an IEC model in vitro, we found that functional suppression of P-gp remarkably facilitated bacterial attachment to Caco-2 cells, leading to subsequent disruption of intestinal barrier function. Of note, Occludin was significantly downregulated by bacterial attachment when P-gp was functionally suppressed. Mechanistically, changes on Occludin were attributed to enhanced protein degradation instead of suppressed protein translation. Despite the half-life of Occludin protein being unchanged by DH5α treatment alone, it was decreased by about 40% when P-gp was simultaneously suppressed. Taken together, our findings revealed that early downregulation of intestinal P-gp under TPN may be a potential therapeutic target to prevent the development of barrier dysfunction.